Loading...

AxoGen, Inc.

AXGN•NASDAQ
Healthcare
Medical - Devices
$13.43
$0.44(3.39%)

AxoGen, Inc. (AXGN) Stock Overview

Explore AxoGen, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 71.8/100

Key Financials

Market Cap611.7M
P/E Ratio-85.32
EPS (TTM)$-0.16
ROE-0.07%
Fundamental Analysis

AI Price Forecasts

1 Week$9.55
1 Month$12.18
3 Months$20.15
1 Year Target$22.86

AXGN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of AxoGen, Inc. (AXGN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 66.54, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $22.86.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -85.32 and a market capitalization of 611.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;